By analyzing whole-exome sequencing results from an advanced prostate cancer patient cohort, we explored potentially activating alterations in the PI3K pathway and identified oncogenic alterations across the dominant drivers of PI3K signaling (PTEN, PIK3CA, PIK3CB, PIK3R1) (Fig. 1a). The gene discussed is PIK3CA; the disease is Familial prostate cancer.